Pay in 4 interest-free payments of $7.29 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
In phase 3 trials of adalimumab (PIONEER I and II), the proportion of patients achieving HS Clinical Response (HiSCR) at week 12 (primary endpoint) was significantly higher with adalimumab administered weekly compared to placebo (41.8% vs
This route also avoids subcutaneous injection
With a centralization of lawsuits in a Pennsylvania federal court, pharmaceutical companies face a troubling legal challenge
Im spending my time and resources to educate people, because in the marketplace, theres so much noise that the people are kind of getting buried into this sea of information
US$ 29.13
US$ 21.02
US$ 27.64
US$ 23.59
US$ 25.87
US$ 20.59
